ETON

NASDAQ 已收盘

Eton Pharmaceuticals

61.36 USD
▼-0.63-1.02%
盘后 61.00 -0.59%
2026-11-19
市值
$1.76B
市盈率
38.06
EPS
1.60
股息率
—
52 周区间
14.27 – 70.64
成交量
389.08K
Beta
0.83
目标价
80.75
52W 低 14.2752W 高 70.64
价格走势

公司简介

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing vari...